Pearl River Capital’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-24,062
| Closed | -$635K | – | 306 |
|
|
2024
Q2 | $635K | Sell |
24,062
-46,531
| -66% | -$1.23M | 0.1% | 243 |
|
|
2024
Q1 | $2.14M | Buy |
70,593
+19,146
| +37% | +$581K | 0.34% | 91 |
|
|
2023
Q4 | $1.45M | Sell |
51,447
-17,072
| -25% | -$480K | 0.23% | 133 |
|
|
2023
Q3 | $1.86M | Sell |
68,519
-8,990
| -12% | -$244K | 0.29% | 116 |
|
|
2023
Q2 | $2.38M | Buy |
+77,509
| New | +$2.38M | 0.38% | 77 |
|
|
2023
Q1 | – | Sell |
-36,796
| Closed | -$1.45M | – | 603 |
|
|
2022
Q4 | $1.45M | Buy |
36,796
+5,900
| +19% | +$233K | 0.25% | 128 |
|
|
2022
Q3 | $1.24M | Buy |
+30,896
| New | +$1.24M | 0.23% | 141 |
|
|
2022
Q2 | – | Sell |
-23,024
| Closed | -$897K | – | 548 |
|
|
2022
Q1 | $897K | Buy |
23,024
+2,724
| +13% | +$106K | 0.25% | 126 |
|
|
2021
Q4 | $809K | Buy |
20,300
+10,878
| +115% | +$434K | 0.22% | 149 |
|
|
2021
Q3 | $341K | Sell |
9,422
-10,547
| -53% | -$382K | 0.09% | 288 |
|
|
2021
Q2 | $819K | Buy |
+19,969
| New | +$819K | 0.23% | 148 |
|